Kommentar
The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease
JAMA Surgery · 2024
DOI: 10.1001/jamasurg.2023.6389 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, 2024. Verfasst von Juliet C Dalton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University Medical Center, Durham, North Carolina. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Breast NeoplasmsBreast DiseasesHumansFemaleBreastRisk AssessmentRiskRisk Factors
Autor:innen und Institutionen
- Department of Surgery, Duke University Medical Center, Durham, North Carolina.
- Duke Cancer Institute, Duke University, Durham, North Carolina.
- Department of Population Health Sciences, Duke University Medical Center, Durham, North Carolina.
Zitieren
APA
Dalton, J. C., Chiba, A., & Plichta, J. K. (2024). The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.6389
Vancouver
Dalton JC, Chiba A, Plichta JK. The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease. JAMA Surgery. 2024. doi:10.1001/jamasurg.2023.6389
BibTeX
@article{Dalton2024,
author = {Dalton, Juliet C and Chiba, Akiko and Plichta, Jennifer K},
title = {The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease},
journal = {JAMA Surgery},
year = {2024},
doi = {10.1001/jamasurg.2023.6389}
}
EUVIMED